申请人:Abbott Laboratories
公开号:US05545750A1
公开(公告)日:1996-08-13
A retroviral protease inhibiting compound of the formula A--X--B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is (1) substituted amino, (2) substituted carbonyl, (3) functionalized imino, (4) functionalized alkyl, (5) functionalized acyl, (6) functionalized heterocyclic or (7) functionalized (heterocyclic)alkyl; and B is (1) substituted carbonyl independently defined as herein, (2) substituted amino independently defined as herein, (3) functionalized imino independently defined as herein, (4) functionalized alkyl independently defined as herein, (5) functionalized acyl independently defined as herein, (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein.
一种具有以下结构的逆转录病毒蛋白酶抑制剂化合物A-X-B或其药学上可接受的盐、前药或酯,其中X是连接基;A是(1)取代的氨基,(2)取代的羰基,(3)官能化的亚胺基,(4)官能化的烷基,(5)官能化的酰基,(6)官能化的杂环基或(7)官能化的(杂环)烷基;B是(1)独立于此处定义的取代的羰基,(2)独立于此处定义的取代的氨基,(3)独立于此处定义的官能化亚胺基,(4)独立于此处定义的官能化烷基,(5)独立于此处定义的官能化酰基,(6)独立于此处定义的官能化杂环基或(7)独立于此处定义的官能化(杂环)烷基。